Sybil Danby

Sybil Danby currently serves as the VP of Business Development and Strategy at Asimov since November 2025. Previously, Sybil held multiple leadership roles at Cytiva, working as the General Manager for Cell Lines and the Global Commercial Leader for Viral Vector from May 2023 to October 2025. At the Center for Breakthrough Medicines, Sybil focused on Business Development and Strategy from August 2020 to May 2023. Prior experience includes serving as Senior Director of Business Development at Paragon Bioservices, Inc., and as Sales Manager for Cell Culture Technologies at Pall Corporation. Sybil began a career in the biopharmaceutical industry at GSK, where positions included Senior Scientist and Biopharmaceutical Manufacturing Associate. Sybil holds a Master’s degree in Biology from West Chester University of Pennsylvania and a Bachelor’s degree in Biology from the University of Rochester.